FDA Warns Multiple Sclerosis Drug May Cause Stroke, Arterial Tears
(November 30, 2018, 1:07 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Nov. 29 warned that some multiple sclerosis patients taking Lemtrada brand alemtuzumab have experienced rare strokes or tears in arteries leading...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login